GEVA
SYNAGEVA BIOPHARMA CORP COM STK (DE)
GEVA
GEVA
Delisted
GEVA was delisted on the 22nd of June, 2015.
84 hedge funds and large institutions have $1.98B invested in SYNAGEVA BIOPHARMA CORP COM STK (DE) in 2013 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 41 increasing their positions, 23 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
12% less funds holding
Funds holding: 95 → 84 (-11)
58% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 19
Holders
84
Holding in Top 10
2
Calls
$6.14M
Puts
$1.47M
Top Buyers
| 1 | +$17.3M | |
| 2 | +$16.2M | |
| 3 | +$9.33M | |
| 4 |
ACH
ArrowMark Colorado Holdings
Denver,
Colorado
|
+$8.49M |
| 5 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
+$8.43M |
Top Sellers
| 1 | -$16.9M | |
| 2 | -$12.7M | |
| 3 | -$10.8M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$9.54M |
| 5 |
EA
Emerald Advisers
Leola,
Pennsylvania
|
-$5.43M |